KALARIS THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $61.3M | $286.6M | $201.7M |
| FY2022 | $52.6M | $277.1M | $106.1M |
| FY2023 | $45.0M | $190.8M | $90.1M |
| FY2024 | $56.8M | $6.2M | $1.6M |
| FY2025 | $42.9M | $121.7M | $98.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $61.3M | $286.6M | $201.7M |
| FY2022 | $52.6M | $277.1M | $106.1M |
| FY2023 | $45.0M | $190.8M | $90.1M |
| FY2024 | $56.8M | $6.2M | $1.6M |
| FY2025 | $42.9M | $121.7M | $98.1M |